# SOME DESCRIPTIVE TITLE.
# Copyright (C) YEAR THE PACKAGE'S COPYRIGHT HOLDER
# This file is distributed under the same license as the PACKAGE package.
# FIRST AUTHOR <EMAIL@ADDRESS>, YEAR.
#
#, fuzzy
msgid ""
msgstr ""
"Project-Id-Version: PACKAGE VERSION\n"
"Report-Msgid-Bugs-To: \n"
"POT-Creation-Date: 2025-06-27 16:48+0000\n"
"PO-Revision-Date: YEAR-MO-DA HO:MI+ZONE\n"
"Last-Translator: FULL NAME <EMAIL@ADDRESS>\n"
"Language-Team: LANGUAGE <LL@li.org>\n"
"Language: \n"
"MIME-Version: 1.0\n"
"Content-Type: text/plain; charset=UTF-8\n"
"Content-Transfer-Encoding: 8bit\n"
"Plural-Forms: nplurals=2; plural=(n != 1);\n"

#: home/templates/home/home.html:30
#, fuzzy
#| msgid "Team"
msgid "The Team"
msgstr "Team"

#: home/templates/home/home.html:32
msgid ""
"Based on CBM (Centro de Biolog√≠a Molecular Severo Ochoa - CSIC), our team "
"focuses on the molecular genetics of Leishmania parasites, the causative "
"agents of leishmaniasis. Using state-of-the-art technology both in vitro and "
"in silico, we study the gene expression and genomic plasticity in these "
"parasites."
msgstr ""

#: home/templates/home/home.html:34
msgid "Learn more"
msgstr ""

#: home/templates/home/home.html:64
msgid "Global Leishmaniasis Distribution"
msgstr ""

#: home/templates/home/home.html:68
msgid ""
"Interactive map showing the global distribution of leishmaniasis cases "
"reported to the World Health Organization (WHO). This visualization helps "
"understand the worldwide impact and spread of the disease."
msgstr ""

#: home/templates/home/home.html:89
msgid "Social Media"
msgstr ""

#: home/templates/home/home.html:90
msgid "Stay updated with news from our partner institutions through BlueSky"
msgstr ""

#: home/views.py:13
#, fuzzy
#| msgid "Team"
msgid "Team 2024"
msgstr "Team"

#: home/views.py:17
#, fuzzy
#| msgid "Team"
msgid "Team old"
msgstr "Team"

#: home/views.py:21
msgid "Leish Lab pre 2024"
msgstr ""

#: home/views.py:29
msgid "What is Leishmaniasis?"
msgstr ""

#: home/views.py:31
msgid ""
"Leishmaniasis is a disease that affects a large population in tropical and "
"subtropical areas worldwide. According to recent data from the World Health "
"Organization, it is estimated that there are between 700,000 to 1,000,000 "
"new cases annually, affecting 90 countries across all continents (World "
"Health Organization, 2023). Currently, around 350 million people are at risk "
"of infection, with 15 million already affected, making it one of the most "
"infectious diseases globally, causing approximately 70,000 deaths each year "
"(Saini et al., 2022)."
msgstr ""

#: home/views.py:41
msgid "Leishmania Parasite"
msgstr ""

#: home/views.py:43
msgid ""
"The disease is transmitted by a protozoan parasite from the trypanosomatid "
"family. This family is also responsible for Chagas disease (Trypanosoma "
"cruzi), sleeping sickness (T. brucei), and leishmaniasis (Leishmania spp.) "
"(Bringaud et al., 2007)."
msgstr ""

#: home/views.py:50
msgid "Leishmaniasis Vector"
msgstr ""

#: home/views.py:52
msgid ""
"Leishmaniasis is specifically transmitted through the bite of a sandfly "
"(subfamily Phlebotominae), leading to the parasite's invasion of the host's "
"internal organs (Herwaldt, 1999)."
msgstr ""

#: species/templates/species/braziliensis.html:13
#: species/templates/species/donovani.html:14
#: species/templates/species/infantum.html:14
#: species/templates/species/major.html:13
msgid "Description"
msgstr ""

#: species/templates/species/braziliensis.html:14
#: species/templates/species/donovani.html:15
#: species/templates/species/infantum.html:15
#: species/templates/species/major.html:14
msgid "Browser"
msgstr ""

#: species/templates/species/braziliensis.html:22
msgid ""
"\n"
"          <p>Protozoan parasite that causes mucocutaneous leishmaniasis, "
"primarily affecting humans. This parasite is transmitted through the bites "
"of infected female phlebotomine sandflies. Mucocutaneous leishmaniasis, also "
"known as espundia, typically starts with skin lesions that can metastasize "
"to mucous membranes, particularly those of the nose, mouth, and throat. "
"Symptoms in humans initially include sores at the site of the sandfly bite, "
"which can progress to destructive lesions of the mucous membranes, leading "
"to severe disfigurement and functional impairment if left untreated.</p>\n"
"          <p>The life cycle of <i>L. braziliensis</i> involves two main "
"stages: the promastigote form, found in the sandfly vector, and the "
"amastigote form, which multiplies within the host's macrophages. In the "
"sandfly, the parasite exists as motile promastigotes. Upon transmission to "
"the human host, the promastigotes are phagocytosed by macrophages and "
"transform into non-motile amastigotes. These amastigotes then multiply "
"within the macrophages, causing cell rupture and infection of new "
"macrophages, leading to the dissemination of the parasite.</p>\n"
"          <p>Control and prevention of leishmaniasis caused by <i>L. "
"braziliensis</i> involve integrated approaches, including vector control "
"through insecticides and environmental management, early diagnosis, and "
"appropriate treatment of infected individuals. Current treatments for "
"mucocutaneous leishmaniasis include antimonial compounds, amphotericin B, "
"pentamidine, and miltefosine. The management of the disease is challenging "
"due to issues such as drug resistance, adverse effects, and the need for "
"prolonged treatment courses. Advances in molecular biology and genomics have "
"deepened the understanding of <i>L. braziliensis</i>'s biology and "
"pathogenic mechanisms, paving the way for potential new therapies and "
"vaccines. Despite these scientific advances, mucocutaneous leishmaniasis "
"remains a significant public health issue, particularly in endemic regions "
"with limited access to healthcare and effective vector control measures.</"
"p>\n"
"        "
msgstr ""

#: species/templates/species/braziliensis.html:35
#: species/templates/species/donovani.html:36
#: species/templates/species/infantum.html:52
#: species/templates/species/major.html:35
msgid "File"
msgstr ""

#: species/templates/species/braziliensis.html:36
#: species/templates/species/donovani.html:37
#: species/templates/species/infantum.html:53
#: species/templates/species/major.html:36
msgid "Reference Genome"
msgstr ""

#: species/templates/species/braziliensis.html:37
#: species/templates/species/donovani.html:38
#: species/templates/species/infantum.html:54
#: species/templates/species/major.html:37
msgid "Version/Year"
msgstr ""

#: species/templates/species/braziliensis.html:38
#: species/templates/species/donovani.html:39
#: species/templates/species/infantum.html:55
#: species/templates/species/major.html:38 templates/html/base.html:54
#: templates/html/base.html:82
msgid "Downloads"
msgstr "Downloads"

#: species/templates/species/braziliensis.html:39
#: species/templates/species/donovani.html:40
#: species/templates/species/infantum.html:56
#: species/templates/species/major.html:39
msgid "Raw Data"
msgstr ""

#: species/templates/species/braziliensis.html:40
#: species/templates/species/donovani.html:41
#: species/templates/species/infantum.html:57
#: species/templates/species/major.html:40
msgid "Notes"
msgstr ""

#: species/templates/species/braziliensis.html:46
#: species/templates/species/donovani.html:47
#: species/templates/species/infantum.html:63
#: species/templates/species/major.html:46
msgid "file"
msgstr ""

#: species/templates/species/braziliensis.html:49
#: species/templates/species/donovani.html:50
#: species/templates/species/infantum.html:66
#: species/templates/species/major.html:49
msgid "DOWNLOAD"
msgstr ""

#: species/templates/species/donovani.html:23
msgid ""
"\n"
"          <p>Protozoan parasite that is the primary causative agent of "
"visceral leishmaniasis, also known as kala-azar. This severe form of "
"leishmaniasis affects internal organs, particularly the liver, spleen, and "
"bone marrow, and can be fatal if left untreated. The parasite is transmitted "
"to humans and other mammals through the bites of infected female "
"phlebotomine sandflies. In humans, <i>L. donovani</i> infection manifests "
"with symptoms such as prolonged fever, significant weight loss, "
"hepatosplenomegaly (enlarged liver and spleen), anemia, and a marked "
"reduction in white blood cell counts.</p>\n"
"          <p>The life cycle of <i>L. donovani</i> involves two main stages: "
"the promastigote form, which resides in the sandfly vector, and the "
"amastigote form, which multiplies within the host's macrophages. In the "
"sandfly, <i>L. donovani</i> exists as motile promastigotes. Upon "
"transmission to the human host, the promastigotes are phagocytosed by "
"macrophages and transform into non-motile amastigotes. These amastigotes "
"proliferate within the macrophages, causing cell rupture and dissemination "
"to other macrophages, leading to widespread infection of the "
"reticuloendothelial system.</p>\n"
"          <p>Control and prevention of visceral leishmaniasis caused by "
"<i>L. donovani</i> require a multi-faceted approach, including sandfly "
"vector control, early diagnosis, prompt treatment of infected individuals, "
"and management of reservoir hosts. Current treatments for visceral "
"leishmaniasis include antimonial compounds, amphotericin B, miltefosine, and "
"paromomycin. However, challenges such as drug resistance, toxicity, and the "
"need for prolonged treatment regimens complicate effective management. "
"Advances in molecular biology and genomics have greatly enhanced the "
"understanding of <i>L. donovani</i>'s biology and pathogenic mechanisms, "
"facilitating the development of new therapeutic strategies and potential "
"vaccines. Despite these advances, visceral leishmaniasis remains a major "
"public health concern, particularly in resource-limited regions where access "
"to healthcare and effective vector control measures are inadequate.</p>\n"
"        "
msgstr ""

#: species/templates/species/infantum.html:23
msgid ""
"\n"
"          <p>Protozoan parasite responsible for the disease leishmaniasis, "
"primarily affecting both humans and\n"
"            animals. This parasite is transmitted through the bites of "
"infected female phlebotomine sandflies.\n"
"            The disease manifests in various forms, with the most severe "
"being visceral leishmaniasis, also\n"
"            known as kala-azar, which can be fatal if left untreated. In "
"humans, <i>L. infantum</i> infection\n"
"            leads to symptoms such as fever, weight loss, hepatosplenomegaly "
"(enlarged liver and spleen),\n"
"            anemia, and a significant drop in white blood cell counts. The "
"parasite predominantly affects\n"
"            internal organs, including the liver, spleen, and bone marrow. "
"In dogs, which are the primary\n"
"            reservoir hosts, the infection can result in skin lesions, "
"lymphadenopathy, and general systemic\n"
"            illness, contributing to the spread of the disease to humans.</"
"p>\n"
"            <p><i>L. infantum</i> has a complex life cycle involving two "
"main stages: the promastigote form found in\n"
"            the sandfly vector and the amastigote form that multiplies "
"within the host's macrophages. Control\n"
"            and prevention of leishmaniasis caused by <i>L. infantum</i> "
"involve integrated approaches,\n"
"            including vector control, early diagnosis, and treatment of "
"infected individuals, as well as\n"
"            management of reservoir hosts. Current treatments for visceral "
"leishmaniasis include antimonial\n"
"            compounds, amphotericin B, and miltefosine, although drug "
"resistance and adverse effects pose\n"
"            significant challenges. Advances in molecular biology and "
"genomics have facilitated a deeper\n"
"            understanding of the parasite's biology and pathogenic "
"mechanisms, paving the way for potential new\n"
"            therapies and vaccines. However, leishmaniasis remains a major "
"public health concern, particularly\n"
"            in regions where vector control and access to healthcare are "
"limited.</p>\n"
"        "
msgstr ""

#: species/templates/species/major.html:22
msgid ""
"\n"
"          <p>Protozoan parasite that causes cutaneous leishmaniasis, "
"primarily affecting humans and some animals. The parasite is transmitted to "
"hosts through the bites of infected female phlebotomine sandflies. Cutaneous "
"leishmaniasis, the most common form of the disease, typically results in "
"skin lesions that can lead to significant scarring and disability. Symptoms "
"in humans include the development of one or more sores at the site of the "
"sandfly bite, which may progress to ulcers with a raised edge. These sores "
"often heal spontaneously over months to years, but they can leave "
"disfiguring scars and may be prone to secondary infections.</p>\n"
"          <p>The life cycle of <i>L. major</i> involves two main stages: the "
"promastigote form, which is found in the sandfly vector, and the amastigote "
"form, which multiplies within the host's macrophages. In the sandfly, the "
"parasite exists as motile promastigotes. Once transmitted to the human host, "
"the promastigotes are phagocytosed by macrophages and transform into non-"
"motile amastigotes. These amastigotes then multiply within the macrophages, "
"leading to cell rupture and further spread of the infection to new "
"macrophages.</p>\n"
"          <p>Control and prevention of leishmaniasis caused by <i>L. major</"
"i> involve integrated approaches, including sandfly vector control through "
"insecticide use and environmental management, early diagnosis, and treatment "
"of infected individuals. Current treatments for cutaneous leishmaniasis "
"include topical and systemic therapies such as antimonial compounds, "
"miltefosine, and amphotericin B. However, the effectiveness of treatments "
"can vary, and issues such as drug resistance and adverse effects continue to "
"pose significant challenges. Advances in molecular biology and genomics have "
"enhanced the understanding of <i>L. major</i>'s biology and pathogenic "
"mechanisms, offering hope for new therapeutic approaches and potential "
"vaccines. Despite these advances, cutaneous leishmaniasis remains a "
"significant public health issue, particularly in endemic regions where "
"access to healthcare and effective vector control measures are limited.</p>\n"
"        "
msgstr ""

#: templates/html/base.html:24
msgid "Genome decoding"
msgstr "Genome decoding"

#: templates/html/base.html:38 templates/html/base.html:66
msgid "About Us"
msgstr "About Us"

#: templates/html/base.html:40 templates/html/base.html:68
msgid "Mission"
msgstr "Mission"

#: templates/html/base.html:41 templates/html/base.html:69
msgid "Team"
msgstr "Team"

#: templates/html/base.html:45 templates/html/base.html:73
msgid "Species"
msgstr "Species"

#: templates/html/base.html:56 templates/html/base.html:84
msgid "Reports"
msgstr "Reports"

#: templates/html/base.html:57 templates/html/base.html:85
msgid "Datasets"
msgstr "Datasets"

#: templates/html/base.html:58 templates/html/base.html:86
msgid "Software"
msgstr "Software"
